Inhibition of the nucleoside transporter inhibits disease progression in the rat adjuvant-induced arthritis model

Drug Development Research

Volumn 58, Issue 4, 2003, Pages 479-485

  Kosaka, Hidekazu ^a   Koshiba, Masahiro ^a   Nakazawa, Takashi ^a   Tsuji, Goh ^a   Saegusa, Jun ^a   Kanagawa, Sugayo ^a   Saura, Ryuichi ^a   Kurosaka, Masahiro ^a   Yoshino, Shin ^b   Kumagai, Shunichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Adenosine; Adjuvant induced arthritis; Nucleoside transporter inhibitor

Indexed keywords

CARRIER PROTEIN; NITROBENZYLTHIOINOSINE; NUCLEOSIDE TRANSPORTER INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; BODY WEIGHT; BONE DESTRUCTION; BONE EROSION; CARTILAGE DEGENERATION; CELL INFILTRATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; HINDLIMB; HISTOPATHOLOGY; MALE; MYCOBACTERIUM BUTYRICUM; NONHUMAN; NUCLEOSIDE TRANSPORT; RADIOGRAPHY; RAT; RAT STRAIN; SCORING SYSTEM;

EID: 0038387510     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10175     Document Type: Conference Paper

References (29)

1. Abbracchio MP, Burnstock G. 1998. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78:113-145.
2. Bouma MG, Jeunhomme TM, Boyle DL, Dentener MA, Voitenok NN, van den Wildenberg FA, Buurman WA. 1997. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J Immunol 158:5400-5408.
3. Boyle DL, Sajjadi FG, Firestein GS. 1996. Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum 39:923-930.
4. Cass CE, Young JD, Baldwin SA. 1998. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol 76:761-770.
5. Clark RL, Cuttino JT Jr, Anderle SK, Cromartie WJ, Schwab JH. 1979. Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls. Arthritis Rheum 22:25-35.
6. Cronstein BN, Naime D, Ostad E. 1993. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 92:2675-2682.
7. Dalziel HH, Westfall DP. 1994. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev 46:449-466.
8. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, et al. 1994. Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
9. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ. 1972. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067-1069.
10. Gilbertsen RB. 1985. Effects of pentostatin (2′deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats. J Immunopharmacol 7:325-341.
11. Haque MA, Yoshino S, Inada S, Nomaguchi H, Tokunaga O, Kohashi O. 1996. Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein. Eur J Immunol 26:2650-2656.
12. Hwang KK, Hall CS, Spielman WS, Sparks HV. 2001. FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase. Eur J Pharmacol 425:85-93.
13. Jaffee BD, Kerr JS, Jones EA, Giannaras JV, McGowan M, Ackerman NR. 1989. The effect of immunomodulating drugs on adjuvant-induced arthritis in Lewis rats. Agents Actions 27:344-346.
14. Klabunde RE. 1983. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 93:21-26.
15. Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky MV. 1997. Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J Biol Chem 272:25881-25889.
16. Koshiba M, Kosaka H, Nakazawa T, Hayashi N, Saura R, Kitamura N, Kumagai S. 2002. 2-Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling. Br J Pharmacol 135:1477-1486.
17. Langenegger T, Michel BA. 1999. Drug treatment for rheumatoid arthritis. Clin Orthop:22-30.
18. Montesinos MC, Yap JS, Desai A, Posadas I, McCrary CT, Cronstein BN. 2000. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis. Arthritis Rheum 43:656-663.
19. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, et al. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein [see comments]. N Engl J Med 337:141-147.
20. Panayi GS, Lanchbury JS, Kingsley GH. 1992. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735.
21. Pettersson T, Klockars M, Weber TH, von Essen R. 1988. Adenosine deaminase activity in joint effusions. Scand J Rheumatol 17:365-369.
22. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
23. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS. 1996. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 156:3435-3442.
24. Steiner G, Tohidast AM, Witzmann G, Vesely M, Studnicka BA, Gal A, Kunaver M, et al. 1999. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology (Oxford) 38:202-213.
25. Szabo C, Scott GS, Virag L, Egnaczyk G, Salzman AL, Shanley TP, Hasko G. 1998. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 125:379-387.
26. Thorn JA, Jarvis SM. 1996. Adenosine transporters. Gen Pharmacol 27:613-620.
27. Weinblatt ME. 1999. The role of current strategies in the future treatment of rheumatoid arthritis. Rheumatology (Oxford) 2:19-23.
28. Wicks I, Cooley H, Szer J. 1997. Autologous hemopoietic stem cell transplantation: a possible cure for rheumatoid arthritis? Arthritis Rheum 40:1005-1011.
29. Zvaifler NJ, Firestein GS. 1994. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37:783-789.